TPH2 and Atypical behavior: Therefore, our negative result indicates that intraperitoneal BH4 administration cannot increase TPH2 activity, 5-HT levels and metabolism or correct the behavioral disorder caused by low TPH2 activity due to an extremely low level of drug penetration in the brain.